| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/09/2008 | CN100360183C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/09/2008 | CN100360182C Induction of antigen specific immunologic tolerance |
| 01/09/2008 | CN100360180C Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/09/2008 | CN100360174C Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (t beta 4), analogues, isoforms and other derivatives |
| 01/09/2008 | CN100360173C Lyase treatment for p. carinii |
| 01/08/2008 | US7317142 Immunization of fish with plant-expressed recombinant proteins |
| 01/08/2008 | US7317097 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 01/08/2008 | US7317094 Process for the in vitro culture of different stages of tissular parasites |
| 01/08/2008 | US7317089 Immunmoglobulin specific to tumor necrosis factor (ligand) superfamily, member 13b (tnfsf13b) protein for use in treatment and prevention of autoimmune, inflammatory, respiratory system, skin , blood and cell proliferative disorders |
| 01/08/2008 | US7317087 Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof |
| 01/08/2008 | US7317086 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering |
| 01/08/2008 | US7317084 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 01/08/2008 | US7317082 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferation disorders |
| 01/08/2008 | US7316910 Rapid test for hemolytic streptococcus |
| 01/08/2008 | US7316902 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 01/08/2008 | US7316813 Influenza vaccine composition |
| 01/08/2008 | US7316812 Cells expressing anti-Fc receptor binding components |
| 01/08/2008 | CA2348474C Pharmaceutically active composition and dispensing device |
| 01/08/2008 | CA2306824C Encapsulation method |
| 01/08/2008 | CA2271929C Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 01/08/2008 | CA2163868C Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 01/08/2008 | CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 01/04/2008 | CA2591804A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/04/2008 | CA2557772A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/04/2008 | CA2551537A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/03/2008 | WO2008002933A2 Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof |
| 01/03/2008 | WO2008002893A2 Anti-amyloid antibodies, compositions, methods and uses |
| 01/03/2008 | WO2008002663A2 Immunogenic protein constructs |
| 01/03/2008 | WO2008001108A2 Silicon adjuvant |
| 01/03/2008 | WO2008001063A1 Antibody molecules which bind human il-17 |
| 01/03/2008 | WO2008000789A2 Pharmaceutical compositions containing monoclonal anti idiotypic anti-ca-125 antibody and aluminium derivatives |
| 01/03/2008 | WO2008000783A1 A method for the production of hydrolyzed allergen |
| 01/03/2008 | WO2008000261A2 Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
| 01/03/2008 | WO2008000137A1 Oral encapsulated preparation for aquatic animals, process for the preparation of same, and usage of same |
| 01/03/2008 | WO2008000028A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 01/03/2008 | WO2007129093A3 Hla peptide therapy |
| 01/03/2008 | WO2007127347A3 An isolated dna fragment of the sparc human promoter and its use |
| 01/03/2008 | WO2007126455A3 Method for using boc/cdo to modulate hedgehog signaling |
| 01/03/2008 | WO2007107488A3 Vaccine against trypanosoma cruzi infection |
| 01/03/2008 | WO2007106811A3 Method and composition for treatment of renal disease with antibodies and their equivalents |
| 01/03/2008 | WO2007103565A3 Wnv dna vaccine incorporating a cmv/r backbone and expressing wnv prm and e proteins |
| 01/03/2008 | WO2007098371A3 Use of flagellin to prevent and treat gram negative bacterial infection |
| 01/03/2008 | WO2007089303A3 Methods and compositions for diagnosing ankylosing spondylitis using biomarkers |
| 01/03/2008 | WO2007082105A3 Chlamydia vaccine |
| 01/03/2008 | WO2007064727A3 Penetrabodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases |
| 01/03/2008 | WO2007062222A3 Inhibition of cell proliferation |
| 01/03/2008 | WO2007060550A3 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
| 01/03/2008 | WO2007051077A3 Methods and compounds for lymphoma cell detection and isolation |
| 01/03/2008 | WO2007049155A3 Compositions comprising yersinia pestis antigens |
| 01/03/2008 | WO2007047763A3 Bcr-abl vaccines and methods of use thereof |
| 01/03/2008 | WO2007006581A3 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/03/2008 | WO2006119115A3 Anti-il-6 antibodies, compositions, methods and uses |
| 01/03/2008 | WO2006109174A3 Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid |
| 01/03/2008 | WO2005123131A3 High pressure spray-dry of bioactive materials |
| 01/03/2008 | WO2005079232A3 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK |
| 01/03/2008 | WO2003085085A3 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
| 01/03/2008 | US20080004561 Method for Treating Oncological, Virulent and Somatic Diseases, Method for Controlling Treatment Efficiency, Pharmaceutical Agents and Composition for Carrying Out Said Treatment |
| 01/03/2008 | US20080004228 New Expression Tools for Multiprotein Applications |
| 01/03/2008 | US20080004219 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 01/03/2008 | US20080003680 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories |
| 01/03/2008 | US20080003318 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 01/03/2008 | US20080003272 flowable, containing thrombin, Factor XIII, fibrinogen, and a calcium salt; for wound healing in surgery, tissue therapy and/or as supporting material for biological factors; effervescent foams; biodegradable supports, bandages |
| 01/03/2008 | US20080003263 Anti-Gluten Egg Yolk Antibodies for the Treatment of Celiac Disease |
| 01/03/2008 | US20080003243 Oral Anti-Protozoiasis Vaccines Based on Transgenic Plants |
| 01/03/2008 | US20080003242 Botulinum toxin treatment for kinesia |
| 01/03/2008 | US20080003241 High frequency application of botulinum toxin therapy |
| 01/03/2008 | US20080003240 Contacting sample of cell that contains exogenous FGFR3 where contacted cell is capable of BoNT/A intoxication and detecting presence of BoNT/A activity of cell relative to control cell, where difference in BoNT/A activity of contacted cell compared to control cell is indicative of BoNT/A activity |
| 01/03/2008 | US20080003239 Yeast-based Vaccine for Inducing an Immune Response |
| 01/03/2008 | US20080003237 Gram Positive Bacterial Cells Comprising a Disrupted Flagellin Gene, Flagellin-Based Fusion Proteins and Use in Removal of Metal Ions from a Liquid |
| 01/03/2008 | US20080003236 Adenovirus fiber shaft composition and methods of use |
| 01/03/2008 | US20080003235 Vaccine Composition Comprising a Class II Cmh Lignd Coupled With an Antigen, Method for the Preparation and the Use Thereof |
| 01/03/2008 | US20080003234 Secreted campylobacter flagella coregulated proteins as immunogens |
| 01/03/2008 | US20080003233 Recombinant Vaccines Against Caligid Copepods (Sea Lice) and Antigen Sequences Thereof |
| 01/03/2008 | US20080003232 Cpg Single Strand Deoxynucleotides for Use as Adjuvant |
| 01/03/2008 | US20080003231 Method of medically treating an individual |
| 01/03/2008 | US20080003230 Composition for modulating the expression of cell adhesion molecules |
| 01/03/2008 | US20080003229 the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; vaccine |
| 01/03/2008 | US20080003228 Immunotherapy; combination with codeine phosphate, naproxen, diclofenac, indomethacin, or ibuprofen |
| 01/03/2008 | US20080003227 Acetyl CoA Carboxylase Splice Variant and Uses Thereof |
| 01/03/2008 | US20080003226 Method to Reduce Hepatoxicity of Fas-Mediated Apoptosis-Inducing Agents |
| 01/03/2008 | US20080003225 Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors |
| 01/03/2008 | US20080003224 Compositions and methods for treating haematological proliferative disorders |
| 01/03/2008 | US20080003223 Babesia canis vaccine |
| 01/03/2008 | US20080003222 Inhibitors for L1 and Adam10 for the Treatment of Carcinomas |
| 01/03/2008 | US20080003221 Compositions and methods for treating inflammatory lung disease |
| 01/03/2008 | US20080003220 Buffering agents for biopharmaceutical formulations |
| 01/03/2008 | US20080003219 Delivery of an ocular agent |
| 01/03/2008 | US20080003218 Anti-IgE antibodies |
| 01/03/2008 | US20080003217 Ilk inhibitors for the treatment of renal disease |
| 01/03/2008 | US20080003216 Administering an interleukin-18 binding protein (IL-18BP) for inhibiting melanoma cell liver and lung tissue metastasis; IL-18 (IFN gamma-inducing factor) |
| 01/03/2008 | US20080003201 Interleukin-12 as a veterinary vaccine adjuvant |
| 01/03/2008 | US20080003200 Tissue selective binding for prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer |
| 01/03/2008 | US20080003183 Nanoparticle radiosensitizers |
| 01/03/2008 | CA2839595A1 Caspase-8 and inflammation, infection and wound healing |
| 01/03/2008 | CA2656224A1 Combination of fc.gamma.riib antibodies and cd20-specific antibodies and methods of use thereof |
| 01/03/2008 | CA2655874A1 Antibody molecules which bind human il-17 |
| 01/03/2008 | CA2655733A1 Pharmaceutical compositions containing monoclonal anti idiotypic anti-ca-125 antibody and aluminium |
| 01/03/2008 | CA2654271A1 Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
| 01/03/2008 | CA2652957A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |